2015
DOI: 10.1016/j.bbrc.2015.06.176
|View full text |Cite
|
Sign up to set email alerts
|

Down-regulation of Rab5 decreases characteristics associated with maintenance of cell transformation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 27 publications
(35 reference statements)
0
5
0
Order By: Relevance
“…It should be noted that for most studies, A549 cells were used, because these cells were suitable for down-regulation experiments with different shRNA sequences and for transfection experiments with shRNA-resistant Rab5 mutants. Rab5 down-regulation with different shRNA sequences was previously described [ 20 , 39 ]. Control cells were infected with a lentivirus encoding a nonspecific shRNA sequence (plasmid 1864; Addgene, Cambridge, MA).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…It should be noted that for most studies, A549 cells were used, because these cells were suitable for down-regulation experiments with different shRNA sequences and for transfection experiments with shRNA-resistant Rab5 mutants. Rab5 down-regulation with different shRNA sequences was previously described [ 20 , 39 ]. Control cells were infected with a lentivirus encoding a nonspecific shRNA sequence (plasmid 1864; Addgene, Cambridge, MA).…”
Section: Methodsmentioning
confidence: 99%
“…Measurements were performed as previously described [ 39 ], but important modifications were included. First, experiments were performed in the presence of serum, and second, measurements were done for up to 24 h. MTS assay .…”
Section: Methodsmentioning
confidence: 99%
“…Rab5 has been found to be upregulated in many cancers including colorectal cancer [84], breast cancer [75,85], cervical cancer [86], liver cancer [82], lung cancer [87] and pancreatic cancer [88,89]. Overexpression of RAB5A is an indicator of poor prognosis in hepatocellular carcinoma, pancreatic cancer and estrogen receptor positive breast cancer [86,90,91,92]. These studies demonstrated that migration and invasion of cancer cells are directly affected by Rab5 expression levels.…”
Section: Small Gtpases–p85α Interactions and Alterationsmentioning
confidence: 99%
“…[17][18][19][20][21] Specifically, within the family of Rab GTPases, which control endocytic trafficking, Rab5 has been reported to be upregulated in different cancers, including lung adenocarcinoma, 22 pancreatic cancer, 23 ovarian cancer, 24 hepatocellular carcinoma, 25 and OSCC. 18 Rab5 is a small GTPase that controls early endosome dynamics, 26 which has been shown by us and others, to promote the acquisition of different malignant traits, including cell migration and invasion, [27][28][29][30] the epithelial to mesenchymal transition, 23 tumorigenesis in vivo, 31 and metastasis in vivo. 27,30 Intriguingly, Rab5 was recently shown to be upregulated in OSCC and associated with malignant traits in this malignancy, 18 however several issues emerge from these findings.…”
Section: Introductionmentioning
confidence: 99%
“…Rab5 is a small GTPase that controls early endosome dynamics, which has been shown by us and others, to promote the acquisition of different malignant traits, including cell migration and invasion, the epithelial to mesenchymal transition, tumorigenesis in vivo, and metastasis in vivo . Intriguingly, Rab5 was recently shown to be upregulated in OSCC and associated with malignant traits in this malignancy, however several issues emerge from these findings.…”
Section: Introductionmentioning
confidence: 99%